Description
An inhibitor of human neuraminidases (IC50s = 143, 43, 61, and 74 μM, for NEU 1, 2, 3, and 4, respectively); reduces latency to first seizure and increases seizure duration in a rat model of potassium-induced seizures,
Formal name: 5-(acetylamino)-2,6-anhydro-3,5-dideoxy-D-glycero-D-galacto-non-2-enonic acid
Synonyms: DANA
Molecular weight: 291.3
CAS: 24967-27-9
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Neuroscience|Seizure Disorders